Publication | Closed Access

Self-assembled polydopamine nanoparticles improve treatment in Parkinson's disease model mice and suppress dopamine-induced dyskinesia

NanoparticlesNanomedicineSuppress Dopamine-induced DyskinesiaEngineeringNanomaterialsTherapeutic NanomaterialsDisease Model MiceNano-drug DeliveryNeuroscienceBiomedical EngineeringDopamineSelf-assembled Polydopamine NanoparticlesProtein Nanoparticles